|
|
|
|
|
|
Axsome Thera Cmn Stk (AXSM)
|
|
5.80 +0.35 (+6.42%)
|
6/28/2017 4:00pm
|
|
Open:
|
5.55
|
Pre. Close:
|
5.45
|
|
High:
|
5.80
|
Low:
|
5.40
|
|
Volume:
|
188,060
|
Market Cap:
|
136.91M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
5.9 - 5.97
|
5.97 - 6.14
|
|
Low:
|
5.18 - 5.22
|
5.22 - 5.33
|
|
Close:
|
5.67 - 5.77
|
5.77 - 5.99
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-28 4:33:32 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 7.11 One year: 8.31
|
|
Support:
|
Support1: 4.64 Support2: 3.75
|
|
Resistance:
|
Resistance1:
6.09 Resistance2: 7.11
|
|
Pivot:
|
4.72
|
|
Moving Averages:
|
MA(5): 5.46 MA(20): 4.54
MA(100): 4.28 MA(250): 5.93 
|
|
MACD:
|
MACD(12,26):
0.40 Signal(12,26,9): 0.25
|
|
%K %D:
|
%K(14,3): 82.35 %D(3): 82.75
|
|
RSI:
|
RSI(14): 77.82
|
|
52-Week:
|
High: 9.11
Low: 3.53 Change(%): -22.9
|
|
Average Vol(K):
|
3-Month: 318
10-Days 531
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.AXSM has closed below upper band by 8.2%. Bollinger Bands are 152.7% wider than normal. The large width of the bands suggest high volatility as compared to AXSM's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Wed, 28 Jun 2017 21:30:05 GMT
Axsome Therapeutics Inc. (AXSM) Soars 6.42% on June 28
Thu, 22 Jun 2017 07:41:15 GMT
Will Axsome Therapeutics (AXSM) Continue to Surge Higher?
Tue, 07 Jun 2016 19:24:24 GMT
Axsome Therapeutics: An Undervalued Promising CNS Disease Company
Tue, 07 Feb 2017 12:03:39 GMT
Axsome Therapeutics to Present at the 2017 BIO CEO & Investor Conference
Thu, 25 May 2017 13:42:15 GMT
An Analysis Of Axsome Therapeutics' Upcoming Catalysts
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
